当前位置：
X-MOL 学术
›
Diabetes Obes. Metab.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Sotagliflozin for patients with type 2 diabetes: A systematic review and meta-analysis
Diabetes, Obesity and Metabolism ( IF 5.4 ) Pub Date : 2021-09-20 , DOI: 10.1111/dom.14555 Ioannis Avgerinos 1, 2 , Thomas Karagiannis 1, 2 , Panagiota Kakotrichi 1 , Theodoros Michailidis 1, 2 , Aris Liakos 1, 2 , David R Matthews 3, 4 , Apostolos Tsapas 1, 2, 4 , Eleni Bekiari 1, 2
Diabetes, Obesity and Metabolism ( IF 5.4 ) Pub Date : 2021-09-20 , DOI: 10.1111/dom.14555 Ioannis Avgerinos 1, 2 , Thomas Karagiannis 1, 2 , Panagiota Kakotrichi 1 , Theodoros Michailidis 1, 2 , Aris Liakos 1, 2 , David R Matthews 3, 4 , Apostolos Tsapas 1, 2, 4 , Eleni Bekiari 1, 2
Affiliation
To assess the efficacy and safety of sotagliflozin in patients with type 2 diabetes.
中文翻译：
Sotagliflozin 用于 2 型糖尿病患者：系统评价和荟萃分析
评估索格列净在 2 型糖尿病患者中的疗效和安全性。
更新日期：2021-09-20
中文翻译：
Sotagliflozin 用于 2 型糖尿病患者：系统评价和荟萃分析
评估索格列净在 2 型糖尿病患者中的疗效和安全性。
京公网安备 11010802027423号